Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis With Comorbid Conditions and Special Populations

A Review


Am J Clin Dermatol. 2021;22(4):425-442. 

In This Article


Selection of treatments for moderate-to-severe psoriasis with comorbid conditions is complex and requires careful consideration of numerous factors (i.e., costs, patient preferences, and disease severity). Our algorithms may serve as a guide when choosing a biologic for patients with comorbid PsA, MS, CHF, IBD, hepatitis B, LTBI, lymphoma, NMSC, or COVID-19 or in pregnant or pediatric patients.